,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,155,1,1,,74712,444539,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
1,155,1,1,,491236,444539,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
2,157,1,1,,74712,444539,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
3,157,1,1,,491236,444539,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
4,161,1,1,,74712,444539,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
5,161,1,1,,491236,444539,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
6,165,1,1,,74712,444539,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
7,165,1,1,,491236,444539,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
8,167,1,1,,74712,444539,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
9,167,1,1,,491236,444539,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
10,175,1,1,,74712,444539,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
11,175,1,1,,491236,444539,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
12,880,2,1,,29217737,444539,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
13,880,2,1,,29217737,444539,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
14,1204,1,2,,48421995,444539,Inactive,,,,,DSSTox (NCTRER) National Center for Toxicological Research Estrogen Receptor Binding Database,Screening,,
15,1469,1,1,,29217737,444539,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
16,1471,2,1,,29217737,444539,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
17,1479,1,2,,29217737,444539,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
18,1487,1,1,,29217737,444539,Inactive,27436948.0,4000.0,,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
19,1490,2,1,,29217737,444539,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
20,1688,1,1,,29217737,444539,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
21,1766,1,1,,29217737,444539,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
22,1766,1,1,,29217737,444539,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
23,1768,1,1,,29217737,444539,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
24,1768,1,1,,29217737,444539,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
25,2528,1,2,,29217737,444539,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
26,2546,1,1,,29217737,444539,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
27,2551,1,1,,29217737,444539,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
28,2662,2,1,,29217737,444539,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
29,37266,8,2,,103198631,444539,Unspecified,,,5000.0,IC50,Inhibition of alpha-glucosidase activity,Confirmatory,15125954.0,
30,144378,5,7,,103198631,444539,Inactive,1172801.0,12972.0,,,Tested for its ability to induce NAD(P)H quinone reductase activity in cultured Hepa 1c1c7 murine hepatoma cells;Inactive,Other,9857096.0,
31,166551,3,4,,103198631,444539,Unspecified,,,,,Percentage inhibition against release of beta-hexosaminidase from RBL-2H3 cells at 100 uM from control,Other,12951092.0,
32,174708,3,3,,103198631,444539,Unspecified,,,,,Gastric cytoprotective activity in male wistar rat,Other,9191959.0,
33,216252,6,2,,103198631,444539,Unspecified,,,,,In vitro inhibitory activity against the growth of WISH cell derived from human cervical carcinoma was determined; slight effect,Other,14684314.0,
34,248765,9,1,,103198631,444539,Unspecified,,,100.0,IC50,Inhibitory concentration of compound on nitric oxide (NO) production in lipopolysaccharide activated mouse peritoneal macrophages,Confirmatory,15780639.0,
35,252044,3,3,,103198631,444539,Unspecified,,,,,Percent inhibition of nitric oxide (NO) production in lipopolysaccharide activated mouse peritoneal macrophages at 100 uM of compound,Other,15780639.0,
36,332814,2,4,,103198631,444539,Unspecified,,,,,Herbicidal activity against velvetleaf assessed as seed germination at 2.5 mM after 4 days relative to control,Other,,
37,332815,2,4,,103198631,444539,Unspecified,,,,,Herbicidal activity against velvetleaf assessed as seed germination at 1 mM after 4 days relative to control,Other,,
38,332816,2,4,,103198631,444539,Unspecified,,,,,Herbicidal activity against velvetleaf assessed as seed germination at 5 mM after 4 days relative to control,Other,,
39,349486,3,4,,103198631,444539,Inactive,,,,,Inhibition of multinucleated cell formation in RANKL-stimulated mouse RAW264.7 cells after 3 days by TRAP staining,Other,18823786.0,
40,379089,6,2,,103198631,444539,Unspecified,,,671.4,IC50,Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay,Confirmatory,10096863.0,
41,379092,3,4,,103198631,444539,Active,,,,,Growth inhibition of BALB/c mouse cloned 3T3/A31 cells at 10 to 100 ug/mL after 72 hrs by nigrosin assay,Other,10096863.0,
42,388742,12,2,,103198631,444539,Unspecified,113596.0,231.0,,IC50,Inhibition of cataracted human eye lens aldose reductase,Confirmatory,18976928.0,
43,388743,6,3,,103198631,444539,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 20 mins,Other,18976928.0,
44,402400,3,3,,103198631,444539,Unspecified,,,,,"Growth inhibition of last instar larvae of Tenebrio molitor assessed as successful pupation at 120 ug/larvae, applied topically measured every 24 hrs for 30 days",Other,9784153.0,
45,402401,6,1,,103198631,444539,Unspecified,,,,,"Growth inhibition of last instar larvae of Tenebrio molitor assessed as duration of pupal stage at 120 ug/larvae, applied topically measured every 24 hrs for 30 days",Other,9784153.0,
46,447578,3,4,,103198631,444539,Unspecified,2498443.0,3065.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
47,447578,3,4,,103198631,444539,Unspecified,3334210.0,8841.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
48,447578,3,4,,103198631,444539,Unspecified,19865267.0,9734.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
49,447578,3,4,,103198631,444539,Unspecified,26394832.0,79885.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
50,447578,3,4,,103198631,444539,Unspecified,27734403.0,83933.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
51,447578,3,4,,103198631,444539,Unspecified,29839394.0,55869.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
52,447578,3,4,,103198631,444539,Unspecified,30913097.0,51564.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
53,447578,3,4,,103198631,444539,Unspecified,68068066.0,3066.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
54,447578,3,4,,103198631,444539,Unspecified,205371758.0,10013.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
55,447578,3,4,,103198631,444539,Unspecified,259016348.0,9759.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
56,447578,3,4,,103198631,444539,Unspecified,296434519.0,10014.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
57,447579,8,1,,103198631,444539,Active,2498443.0,3065.0,,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
58,447579,8,1,,103198631,444539,Active,3334210.0,8841.0,,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
59,447579,8,1,,103198631,444539,Active,19865267.0,9734.0,,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
60,447579,8,1,,103198631,444539,Active,26394832.0,79885.0,,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
61,447579,8,1,,103198631,444539,Active,27734403.0,83933.0,,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
62,447579,8,1,,103198631,444539,Active,29839394.0,55869.0,,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
63,447579,8,1,,103198631,444539,Active,30913097.0,51564.0,,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
64,447579,8,1,,103198631,444539,Active,68068066.0,3066.0,,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
65,447579,8,1,,103198631,444539,Active,205371758.0,10013.0,,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
66,447579,8,1,,103198631,444539,Active,259016348.0,9759.0,,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
67,447579,8,1,,103198631,444539,Active,296434519.0,10014.0,,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
68,462333,3,3,,103198631,444539,Unspecified,,,,,Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 30 uM after 72 hrs,Other,20189399.0,
69,462342,3,3,,103198631,444539,Unspecified,,,,,Toxicity in mouse B16-4A5 cells assessed as inhibition of cell proliferation at 30 uM in presence of 1 mM theophylline after 72 hrs by WST8 dye reduction assay,Other,20189399.0,
70,465565,7,1,,103198631,444539,Unspecified,,,,,Antituberculosis activity against Mycobacterium tuberculosis H37Rv after 7 days by resazurin microtiter assay,Other,20138519.0,
71,467606,6,6,,103198631,444539,Unspecified,6686057.0,,410.0,IC50,Inhibition of mushroom tyrosinase after 10 mins by spectrophotometry,Confirmatory,19555125.0,
72,471323,5,2,,103198631,444539,Inactive,,,,IC50,Cytotoxicity against human A2780 cells after 4 days by MTT assay,Confirmatory,19702283.0,
73,471324,9,5,,103198631,444539,Inactive,131467.0,5770.0,,IC50,Inhibition of GST-tagged human PTP1B,Confirmatory,19702283.0,
74,471325,6,2,,103198631,444539,Inactive,,,,IC50,Antiviral activity against HIV-1 NL4-3 expressing VSV-G envelope infected in human 293T cells assessed as inhibition of viral replication after 48 hrs by Luciferase reporter gene assay,Confirmatory,19702283.0,
75,477928,3,4,,103198631,444539,Unspecified,,,,,Cytotoxicity against human PANC1 cells in nutrient-deprived condition assessed as preferential cell death after 24 hrs by trypan blue dye exclusion method,Other,20307087.0,
76,485290,1,1,,29217737,444539,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
77,492961,1,1,,29217737,444539,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase: hit validation,Confirmatory,,
78,499617,3,9,,103198631,444539,Unspecified,3219819.0,25155.0,,,Inhibition of spleen tyrosine kinase in rat RBL-2H3 cells assessed as inhibition of IgE-induced degranulation after 1 hr by beta-hexosaminidase release assay,Other,20663674.0,
79,499619,3,9,,103198631,444539,Active,3219819.0,25155.0,,,Inhibition of spleen tyrosine kinase in rat RBL-2H3 cells assessed as inhibition of IgE-induced increase of intracellular calcium level at 50 uM after 30 mins by FLIPR assay,Other,20663674.0,
80,499620,3,9,,103198631,444539,Active,3219819.0,25155.0,,,Inhibition of spleen tyrosine kinase in rat RBL-2H3 cells assessed as inhibition of IgE-induced increase of ROS level at 50 uM after 30 mins by FLIPR assay,Other,20663674.0,
81,499621,3,9,,103198631,444539,Active,3219819.0,25155.0,,,Inhibition of spleen tyrosine kinase in rat RBL-2H3 cells assessed as inhibition of IgE-induced upregulation of phospholipase Cgamma1 level at 50 uM after 30 mins by Western blotting,Other,20663674.0,
82,499622,3,9,,103198631,444539,Active,3219819.0,25155.0,,,Inhibition of spleen tyrosine kinase in rat RBL-2H3 cells assessed as inhibition of IgE-induced upregulation of phospholipase 2 level at 50 uM after 30 mins by Western blotting,Other,20663674.0,
83,499623,3,9,,103198631,444539,Inactive,3219819.0,25155.0,,,Inhibition of spleen tyrosine kinase in rat RBL-2H3 cells assessed as inhibition of IgE-induced upregulation of Lyn level at 50 uM after 30 mins by Western blotting,Other,20663674.0,
84,504327,1,1,,29217737,444539,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
85,504332,1,1,,29217737,444539,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
86,504749,1,3,,29217737,444539,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
87,504749,1,3,1.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
88,504749,1,3,2.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
89,504749,1,3,3.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
90,504749,1,3,4.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
91,504749,1,3,5.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
92,504749,1,3,6.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
93,504749,1,3,7.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
94,504749,1,3,8.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
95,504749,1,3,9.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
96,504749,1,3,10.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
97,504749,1,3,11.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
98,504749,1,3,12.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
99,504749,1,3,13.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
100,504749,1,3,14.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
101,504749,1,3,15.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
102,504749,1,3,16.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
103,504749,1,3,17.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
104,504749,1,3,18.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
105,504749,1,3,19.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
106,504749,1,3,20.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
107,504749,1,3,21.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
108,504749,1,3,22.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
109,504749,1,3,23.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
110,504749,1,3,24.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
111,504749,1,3,25.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
112,504749,1,3,26.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
113,504749,1,3,27.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
114,504749,1,3,28.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
115,504749,1,3,29.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
116,504749,1,3,30.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
117,504749,1,3,31.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
118,504749,1,3,32.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
119,504749,1,3,33.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
120,504749,1,3,34.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
121,504749,1,3,35.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
122,504749,1,3,36.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
123,504749,1,3,37.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
124,504749,1,3,38.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
125,504749,1,3,39.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
126,504749,1,3,40.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
127,504749,1,3,41.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
128,504749,1,3,42.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
129,504749,1,3,43.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
130,504749,1,3,44.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
131,504749,1,3,45.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
132,504749,1,3,46.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
133,504749,1,3,47.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
134,504749,1,3,48.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
135,504749,1,3,49.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
136,504749,1,3,50.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
137,504749,1,3,51.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
138,504749,1,3,52.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
139,504749,1,3,53.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
140,504749,1,3,54.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
141,504749,1,3,55.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
142,504749,1,3,56.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
143,504749,1,3,57.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
144,504749,1,3,58.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
145,504749,1,3,59.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
146,504749,1,3,60.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
147,504749,1,3,61.0,29217737,444539,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
148,504832,1,1,,29217737,444539,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
149,504834,1,1,,29217737,444539,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
150,504847,1,1,,29217737,444539,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
151,504865,1,1,,29217737,444539,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
152,588579,1,1,,29217737,444539,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
153,588834,2,1,,144205832,444539,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
154,590194,3,3,,103198631,444539,Unspecified,,,250.0,EC50,Antioxidant activity assessed as DPPH radical scavenging activity by spectrophotometry,Confirmatory,21377874.0,
155,590195,6,5,,103198631,444539,Unspecified,6686057.0,,350.0,IC50,Inhibition of mushroom tyrosinase after 25 mins by spectrophotometry,Confirmatory,21377874.0,
156,592088,3,2,,103198631,444539,Active,,,0.18,IC50,Antihemorrhagic activity in ddY mouse assessed as inhibition of Protobothrops flavoviridis venom-induced hemorrhage incubated with compound for 10 mins measured after 24 hrs,Confirmatory,21388814.0,
157,594381,6,5,,103198631,444539,Active,74762622.0,338442.0,4.9,Ki,Displacement of [3H]nicotinic acid from human GPR109a receptor expressed in human HEK293T cells by liquid scintillation counting,Confirmatory,21167710.0,
158,602332,1,1,,29217737,444539,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
159,610072,7,2,,103198631,444539,Active,222032844.0,,43.4,IC50,Inhibition of N-terminal His-tagged Escherichia coli FabH expressed in Escherichia coli BL21 (DE3) using [3H]acetyl-coA after 25 mins by liquid scintillation counting,Confirmatory,21741250.0,
160,610073,1,5,,103198631,444539,Unspecified,,,,,Toxicity in erythrocytes assessed as hemolytic activity,Other,21741250.0,
161,617381,1,5,,103198631,444539,Inactive,,,,,Binding affinity to goat brain tubulin by isothermal titration calorimetry,Other,21830815.0,
162,624030,1,2,,29217737,444539,Inactive,160794.0,,,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
163,624031,1,2,,29217737,444539,Inactive,,,,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
164,624032,1,2,,29217737,444539,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
165,624044,1,2,,29217737,444539,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
166,624170,1,1,,29217737,444539,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
167,624172,1,1,,29217737,444539,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
168,624173,1,3,,29217737,444539,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
169,624296,1,1,,29217737,444539,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
170,624297,1,1,,29217737,444539,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
171,634094,3,2,,103198631,444539,Unspecified,,,87.0,IC50,Anticancer activity against human A549 cells after 48 hrs by MTT assay,Confirmatory,22136907.0,
172,634095,3,2,,103198631,444539,Unspecified,,,64.0,IC50,Anticancer activity against human A375 cells after 48 hrs by MTT assay,Confirmatory,22136907.0,
173,634096,3,2,,103198631,444539,Unspecified,,,108.0,IC50,Anticancer activity against human MCF7 cells after 48 hrs by MTT assay,Confirmatory,22136907.0,
174,634097,3,2,,103198631,444539,Unspecified,,,114.0,IC50,Anticancer activity against human HT-29 cells after 48 hrs by MTT assay,Confirmatory,22136907.0,
175,634098,3,2,,103198631,444539,Unspecified,,,91.0,IC50,Anticancer activity against human ACHN cells after 48 hrs by MTT assay,Confirmatory,22136907.0,
176,639826,1,9,,103198631,444539,Unspecified,113596.0,231.0,,,Inhibition of human recombinant aldose reductase using D-glyceraldehyde as substrate at 15 uM preincubated for 10 mins before substrate addition measured for every 10 secs for 50 mins by spectrophotometry,Other,22261024.0,
177,642414,1,9,,103198631,444539,Unspecified,544257.0,2099.0,,,Estrogenic activity at ERalpha in human MVLN cells at 100 ug/mL after 24 hrs by luciferase reporter gene assay relative to E2,Other,22137340.0,
178,642415,1,9,,103198631,444539,Unspecified,544257.0,2099.0,,,Estrogenic activity at ERalpha in human MVLN cells at 20 ug/mL after 24 hrs by luciferase reporter gene assay relative to E2,Other,22137340.0,
179,651631,4,1,,144205832,444539,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
180,651631,4,1,,144212454,444539,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
181,651632,4,1,,144205832,444539,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
182,651632,4,1,,144212454,444539,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
183,651633,4,1,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
184,651633,4,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
185,651634,4,1,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
186,651634,4,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
187,652048,1,2,,144205832,444539,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
188,652051,1,1,,144205832,444539,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
189,670363,1,5,,103198631,444539,Unspecified,,,,,Inhibition of xanthine oxidase- mediated uric acid formation at 50 ug/mL after 5 mins by spectrophotometry,Other,22677314.0,
190,670364,2,4,,103198631,444539,Unspecified,,,,,Inhibition of xanthine oxidase- mediated uric acid formation after 5 mins by spectrophotometry,Other,22677314.0,
191,686978,1,1,,144205832,444539,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
192,686979,1,1,,144205832,444539,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
193,688479,3,1,,103198631,444539,Unspecified,112927.0,351.0,100.0,IC50,Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,Confirmatory,22921742.0,
194,688484,1,3,,103198631,444539,Inactive,112927.0,351.0,,,Inhibition of human amyloid beta (1 to 42) aggregation at 1 to 100 uM after 24 hrs by thioflavin-T fluorescence assay,Other,22921742.0,
195,720516,2,1,,144205832,444539,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
196,720516,2,1,,144212454,444539,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
197,720532,1,1,,144205832,444539,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
198,720533,1,1,,144205832,444539,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
199,720552,2,1,,144205832,444539,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
200,720552,2,1,,144212454,444539,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
201,720634,2,1,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
202,720634,2,1,,144212454,444539,Inactive,,,61.1306,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
203,720635,2,1,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
204,720635,2,1,,144212454,444539,Inconclusive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
205,720637,2,1,,144205832,444539,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
206,720637,2,1,,144212454,444539,Inconclusive,,,0.21689899999999998,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
207,720674,2,2,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
208,720674,2,2,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
209,720675,2,2,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
210,720675,2,2,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
211,720678,2,1,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
212,720678,2,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
213,720679,2,1,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
214,720679,2,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
215,720680,2,1,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
216,720680,2,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
217,720681,2,1,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
218,720681,2,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
219,720682,2,1,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
220,720682,2,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
221,720683,2,1,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
222,720683,2,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
223,720684,2,1,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
224,720684,2,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
225,720685,2,1,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
226,720685,2,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
227,720686,2,1,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
228,720686,2,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
229,720687,2,2,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
230,720687,2,2,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
231,720691,4,1,,144205832,444539,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
232,720691,4,1,,144212454,444539,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
233,720692,3,1,,144205832,444539,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
234,720692,3,1,,144212454,444539,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
235,720693,3,1,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
236,720693,3,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
237,720719,2,1,,144205832,444539,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
238,720719,2,1,,144212454,444539,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
239,720725,2,1,,144205832,444539,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
240,720725,2,1,,144212454,444539,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
241,743012,3,1,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
242,743012,3,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
243,743014,3,1,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
244,743014,3,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
245,743015,3,1,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
246,743015,3,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
247,743033,3,1,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
248,743033,3,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
249,743035,2,1,,144205832,444539,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
250,743035,2,1,,144212454,444539,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
251,743036,2,1,,144205832,444539,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
252,743036,2,1,,144212454,444539,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
253,743040,3,1,,144205832,444539,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
254,743040,3,1,,144212454,444539,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
255,743041,3,1,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
256,743041,3,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
257,743042,3,1,,144205832,444539,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
258,743042,3,1,,144212454,444539,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
259,743053,2,1,,144205832,444539,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
260,743053,2,1,,144212454,444539,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
261,743054,2,1,,144205832,444539,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
262,743054,2,1,,144212454,444539,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
263,743063,2,1,,144205832,444539,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
264,743063,2,1,,144212454,444539,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
265,743064,3,1,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
266,743064,3,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
267,743065,3,1,,144205832,444539,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
268,743065,3,1,,144212454,444539,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
269,743066,3,1,,144205832,444539,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
270,743066,3,1,,144212454,444539,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
271,743067,2,1,,144205832,444539,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
272,743067,2,1,,144212454,444539,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
273,743069,2,1,,144205832,444539,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
274,743069,2,1,,144212454,444539,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
275,743074,2,1,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
276,743074,2,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
277,743075,2,1,,144205832,444539,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
278,743075,2,1,,144212454,444539,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
279,743077,2,1,,144205832,444539,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
280,743077,2,1,,144212454,444539,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
281,743078,2,1,,144205832,444539,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
282,743078,2,1,,144212454,444539,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
283,743079,3,1,,144205832,444539,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
284,743079,3,1,,144212454,444539,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
285,743080,3,1,,144205832,444539,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
286,743080,3,1,,144212454,444539,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
287,743081,3,1,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
288,743081,3,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
289,743083,3,1,,144205832,444539,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
290,743083,3,1,,144212454,444539,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
291,743084,3,1,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
292,743084,3,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
293,743085,3,1,,144205832,444539,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
294,743085,3,1,,144212454,444539,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
295,743086,3,1,,144205832,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
296,743086,3,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
297,743091,2,1,,144205832,444539,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
298,743091,2,1,,144212454,444539,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
299,743094,3,1,,144205832,444539,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
300,743094,3,1,,144212454,444539,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
301,743122,2,1,,144205832,444539,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
302,743122,2,1,,144212454,444539,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
303,743139,2,1,,144205832,444539,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
304,743139,2,1,,144212454,444539,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
305,743140,2,1,,144205832,444539,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
306,743140,2,1,,144212454,444539,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
307,743191,3,1,,144212454,444539,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
308,743194,3,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
309,743199,2,1,,144212454,444539,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
310,743202,4,1,,144212454,444539,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
311,743203,3,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
312,743209,3,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
313,743210,4,1,,144212454,444539,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
314,743211,3,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
315,743212,3,1,,144212454,444539,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
316,743213,3,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
317,743215,3,1,,144212454,444539,Inconclusive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
318,743217,3,1,,144212454,444539,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
319,743218,3,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
320,743219,3,1,,144212454,444539,Inactive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
321,743220,3,1,,144212454,444539,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
322,743221,3,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
323,743222,3,1,,144212454,444539,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
324,743223,3,1,,144212454,444539,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
325,743224,3,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
326,743225,3,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
327,743226,2,1,,144212454,444539,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
328,743227,2,1,,144212454,444539,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
329,743228,3,1,,144212454,444539,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
330,743239,2,1,,144212454,444539,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
331,743240,2,1,,144212454,444539,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
332,743241,2,1,,144212454,444539,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
333,743242,2,1,,144212454,444539,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
334,743244,1,1,,144205832,444539,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
335,750752,1,1,,103198631,444539,Unspecified,,,,,"Dissociation constant, pKa of the compound",Other,23682762.0,
336,750755,1,2,,103198631,444539,Unspecified,,,,,Inhibition of Gloeobacter violaceus ligand-gated ion channel expressed in Xenopus laevis oocytes assessed as inhibition of MES buffer pH 5.5 -induced currents at 1 mM after 30 secs by voltage clamp technique,Other,23682762.0,
337,750756,3,1,,103198631,444539,Active,,,34.6,IC50,Antagonist activity at Gloeobacter violaceus ligand-gated ion channel expressed in Xenopus oocytes assessed as inhibition of MES buffer pH 5.5 -induced currents after 30 secs by voltage clamp technique,Confirmatory,23682762.0,
338,781325,1,2,,103198631,444539,Unspecified,,,,,pKa (acid-base dissociation constant) as determined by Liao ref: J Chem Info Model 2009,Other,24249037.0,
339,1078028,1,2,,103198631,444539,Unspecified,,,,,Antibacterial activity against Mycobacterium smegmatis MC2 155 assessed as growth inhibition,Other,,
340,1078029,1,2,,103198631,444539,Unspecified,,,,,"Selectivity index, ratio of GI50 for mouse RAW264.7 cells to MIC for Mycobacterium tuberculosis H37Rv ATCC 27294",Other,,
341,1078030,1,2,,103198631,444539,Unspecified,,,6547.0,GI50,Cytotoxicity against mouse RAW264.7 cells assessed as growth inhibition after 48 hrs by trypan blue assay,Confirmatory,,
342,1078031,3,1,,103198631,444539,Unspecified,,,,,Antibacterial activity against Mycobacterium bovis BCG ATCC 35734 after 2 weeks by spot culture growth inhibition assay,Other,,
343,1078032,3,1,,103198631,444539,Unspecified,,,,,Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 2 weeks by spot culture growth inhibition assay,Other,,
344,1081643,1,1,,103198631,444539,Unspecified,,,,,Phytotoxicity against Echinochloa crus-galli (barnyard grass) assessed as mortality measured after 3 days at 5 mg/ml by foliar spraying,Other,20839888.0,
345,1085232,1,4,,103198631,444539,Unspecified,126716.0,,,,Inhibition of yeast alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside as substrate preincubated at 300 uM for 10 min before substrate addition and measured after 10 min by spectrophotometry,Other,,
346,1085233,2,3,,103198631,444539,Unspecified,126716.0,,300.0,IC50,Inhibition of yeast alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside as substrate preincubated for 10 min before substrate addition and measured after 10 min by spectrophotometry,Confirmatory,,
347,1090909,1,1,,103198631,444539,Unspecified,,,,,Stimulation of cellulase activity in Fusarium oxysporum f. sp. niveum at 1600 mg/L measured 7 days post compound treatment by DNS method,Other,18211014.0,
348,1090910,1,1,,103198631,444539,Unspecified,,,,,Stimulation of proteinase activity in Fusarium oxysporum f. sp. niveum at 1600 mg/L measured 7 days post compound treatment,Other,18211014.0,
349,1090911,1,1,,103198631,444539,Unspecified,,,,,Stimulation of proteinase activity in Fusarium oxysporum f. sp. niveum at 1600 mg/L measured 7 days post compound treatment by DNS method,Other,18211014.0,
350,1090912,1,1,,103198631,444539,Unspecified,,,,,Growth inhibition of Neurospora crassa assessed as inhibition of mycelial growth at 200 mg/L,Other,18211014.0,
351,1090913,1,1,,103198631,444539,Unspecified,,,,,Growth inhibition of Fusarium oxysporum f. sp. niveum assessed as inhibition of mycelium dry weight at 1600 mg/L measured 7 days post compound treatment,Other,18211014.0,
352,1090914,1,1,,103198631,444539,Unspecified,,,,,Stimulation of amylase activity in Fusarium oxysporum f. sp. niveum at 1600 mg/L measured 7 days post compound treatment by DNS method (Rvb = 3.7 +/- 0.5 umol/min/ml),Other,18211014.0,
353,1090915,1,1,,103198631,444539,Unspecified,,,,,Stimulation of amylase activity in Fusarium oxysporum f. sp. niveum at 400 mg/L measured 7 days post compound treatment by DNS method (Rvb = 3.7 +/- 0.5 umol/min/ml),Other,18211014.0,
354,1090916,1,1,,103198631,444539,Unspecified,,,,,Stimulation of cellulase activity in Fusarium oxysporum f. sp. niveum at 1600 mg/L measured 7 days post compound treatment by DNS method (Rvb = 0.03 +/- 0.1 umol/min/ml),Other,18211014.0,
355,1090917,1,1,,103198631,444539,Unspecified,,,,,Stimulation of proteinase activity in Fusarium oxysporum f. sp. niveum at 1600 mg/L measured 7 days post compound treatment (Rvb = 0.42 +/- 0.2 U//min/ml),Other,18211014.0,
356,1090918,1,1,,103198631,444539,Unspecified,,,,,Stimulation of pectinase activity in Fusarium oxysporum f. sp. niveum at 1600 mg/L measured 7 days post compound treatment by DNS method (Rvb = 0.01 +/- 0.0 U//ml/min),Other,18211014.0,
357,1090919,3,1,,103198631,444539,Unspecified,,,,,Stimulation of mycotoxin production in Fusarium oxysporum f. sp. niveum at 1600 mg/L measured 7 days post compound treatment by spectrophotometry (Rvb = 26.9 +/- 4.9 ug/mL),Other,18211014.0,
358,1090920,1,1,,103198631,444539,Unspecified,,,,,Growth inhibition of Fusarium oxysporum f. sp. niveum assessed as reduction in sporulation measured 7 days post compound treatment,Other,18211014.0,
359,1090921,1,1,,103198631,444539,Unspecified,,,,,Growth inhibition of Fusarium oxysporum f. sp. niveum assessed as reduction in conidial germination measured 7 days post compound treatment,Other,18211014.0,
360,1090922,1,1,,103198631,444539,Unspecified,,,,,Growth inhibition of Fusarium oxysporum f. sp. niveum assessed as colony diameter at 1600 mg/L measured 7 days post compound treatment (Rvb = 7.0 +/- 0.63 cm),Other,18211014.0,
361,1090923,1,1,,103198631,444539,Unspecified,,,,,Growth inhibition of Fusarium oxysporum f. sp. niveum assessed as reduction in hyphal growth measured 7 days post compound treatment,Other,18211014.0,
362,1090924,1,1,,103198631,444539,Unspecified,,,,,Growth inhibition of Fusarium oxysporum f. sp. niveum assessed as mycelium dry weight at 1600 mg/L measured 7 days post compound treatment (Rvb = 0.22 +/- 0.01 g),Other,18211014.0,
363,1099186,1,2,,103198631,444539,Unspecified,,,,,Antimicrobial activity against Athelia rolfsii assessed as growth inhibition at 100 ppm by agar dilution method,Other,,
364,1099187,1,2,,103198631,444539,Unspecified,,,,,Antimicrobial activity against Athelia rolfsii assessed as growth inhibition at 10 ppm by agar dilution method,Other,,
365,1099188,1,2,,103198631,444539,Unspecified,,,,,Antimicrobial activity against Pythium sp. assessed as growth inhibition at 10 ppm by agar dilution method,Other,,
366,1099189,1,2,,103198631,444539,Unspecified,,,,,Antimicrobial activity against Pythium sp. assessed as growth inhibition at 100 ppm by agar dilution method,Other,,
367,1100608,1,1,,103198631,444539,Unspecified,,,,,Antibacterial activity against Ralstonia solanacearum grown on potato semi-synthetic agar medium at 5 umol/disk by paper disk method,Other,84.0,
368,1100609,1,1,,103198631,444539,Inactive,,,,,Antibacterial activity against Ralstonia solanacearum grown on potato semi-synthetic agar medium at 0.5 umol/disk by paper disk method,Other,84.0,
369,1100921,1,1,,103198631,444539,Unspecified,,,,,Insecticidal activity against Mechoris ursulus assessed as mortality at 1 mg/paper at 25 +/- 1 degC measured after 48 hr by filter paper diffusion method,Other,10888580.0,
370,1100922,1,1,,103198631,444539,Unspecified,,,,,Insecticidal activity against Mechoris ursulus assessed as mortality at 2.5 mg/paper at 25 +/- 1 degC measured after 48 hr by filter paper diffusion method,Other,10888580.0,
371,1100923,1,1,,103198631,444539,Unspecified,,,,,Insecticidal activity against Mechoris ursulus assessed as mortality at 5 mg/paper at 25 +/- 1 degC measured after 48 hr by filter paper diffusion method,Other,10888580.0,
372,1112517,1,1,,103198631,444539,Unspecified,,,,,Toxicity to Musca domestica (house fly) applied to pronotum assessed as compound level per fly causing insect mortality measured after 24 hr,Other,22461383.0,
373,1112518,1,4,,103198631,444539,Unspecified,74919269.0,101900690.0,,,Displacement of [3H]TBOB binding to GABA receptor in Musca domestica (house fly) heads homogenates assessed as [3H]TBOB binding at 500 uM incubated for 90 min by scintillation counting method,Other,22461383.0,
374,1113017,1,1,,103198631,444539,Unspecified,,,,,Nematicidal activity against second-stage juveniles of Meloidogyne incognita (root-knot nematode) after 1 day by inverted microscopic analysis,Other,23379671.0,
375,1113018,1,1,,103198631,444539,Unspecified,,,,,Nematicidal activity against second-stage juveniles of Meloidogyne incognita (root-knot nematode) after 1 hr by inverted microscopic analysis,Other,23379671.0,
376,1116048,1,2,,103198631,444539,Inactive,,,,,Inhibition of autoxidation of pure triacylglycerols of sunflower oil at 1 mM by iodometric analysis,Other,,
377,1116049,1,3,,103198631,444539,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 3.6 mM after 20 min,Other,,
378,1116050,1,3,,103198631,444539,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 3.6 mM after 10 min,Other,,
379,1116051,1,3,,103198631,444539,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 1.8 mM after 20 min,Other,,
380,1116052,1,3,,103198631,444539,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 0.9 mM after 20 min,Other,,
381,1116053,1,3,,103198631,444539,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 1.8 mM after 10 min,Other,,
382,1116054,1,3,,103198631,444539,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 0.9 mM after 10 min,Other,,
383,1116633,1,2,,103198631,444539,Unspecified,,,,,Antimicrobial activity against Trichophyton rubrum MTCC 296 assessed as growth inhibition after 5 days by broth microdilution method,Other,,
384,1116634,1,2,,103198631,444539,Unspecified,,,,,Antimicrobial activity against Aspergillus sydowii MTCC 4335 assessed as growth inhibition after 5 days by broth microdilution method,Other,,
385,1116635,1,2,,103198631,444539,Unspecified,,,,,Antimicrobial activity against Aspergillus parasiticus MTCC 2797 assessed as growth inhibition after 5 days by broth microdilution method,Other,,
386,1116636,1,2,,103198631,444539,Unspecified,,,,,Antimicrobial activity against Aspergillus niger MTCC 404 assessed as growth inhibition after 5 days by broth microdilution method,Other,,
387,1116637,1,2,,103198631,444539,Unspecified,,,,,Antimicrobial activity against Pichia kudriavzevii MTCC 231 assessed as growth inhibition after 24 hr by broth microdilution method,Other,,
388,1116638,1,2,,103198631,444539,Unspecified,,,,,Antimicrobial activity against Candida albicans MTCC 3017 assessed as growth inhibition after 24 hr by broth microdilution method,Other,,
389,1116639,1,2,,103198631,444539,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae MTCC 509 assessed as growth inhibition after 24 hr by broth microdilution method,Other,,
390,1116640,1,3,,103198631,444539,Unspecified,,,,,Antimicrobial activity against Pseudomonas aeruginosa MTCC 424 assessed as growth inhibition after 24 hr by broth microdilution method,Other,,
391,1116641,1,2,,103198631,444539,Unspecified,,,,,Antimicrobial activity against Klebsiella pneumoniae MTCC 109 assessed as growth inhibition after 24 hr by broth microdilution method,Other,,
392,1116642,1,2,,103198631,444539,Unspecified,,,,,Antimicrobial activity against Escherichia coli MTCC 43 assessed as growth inhibition after 24 hr by broth microdilution method,Other,,
393,1116643,1,2,,103198631,444539,Unspecified,,,,,Antimicrobial activity against Burkholderia cepacia MTCC 438 assessed as growth inhibition after 24 hr by broth microdilution method,Other,,
394,1116644,1,2,,103198631,444539,Unspecified,,,,,Antimicrobial activity against Micrococcus luteus MTCC 2470 assessed as growth inhibition after 24 hr by broth microdilution method,Other,,
395,1116645,1,2,,103198631,444539,Unspecified,,,,,Antimicrobial activity against Bacillus subtilis MTCC 121 assessed as growth inhibition after 24 hr by broth microdilution method,Other,,
396,1116646,1,2,,103198631,444539,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus MTCC 3160 assessed as growth inhibition after 24 hr by broth microdilution method,Other,,
397,1159399,1,2,,103198631,444539,Unspecified,,,,,ASTRAZENECA: Most acidic pKa value (pKa A1) determined by absorption and potentiometric titration using standard methodology from Sirius Analytical. Experimental range Acids: <= 11.,Other,,
398,1159509,1,1,,144212454,444539,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
399,1159515,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
400,1159516,1,1,,144212454,444539,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
401,1159517,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
402,1159518,1,1,,144212454,444539,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
403,1159519,1,1,,144212454,444539,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
404,1159520,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
405,1159521,1,1,,144212454,444539,Inactive,15928672.0,19885.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
406,1159523,1,1,,144212454,444539,Inactive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
407,1159525,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
408,1159526,1,1,,144212454,444539,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
409,1159527,1,1,,144212454,444539,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
410,1159528,1,1,,144212454,444539,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
411,1159529,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
412,1159531,1,1,,144212454,444539,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
413,1159551,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
414,1159552,1,1,,144212454,444539,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
415,1159553,2,1,,144212454,444539,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
416,1159555,1,1,,144212454,444539,Inactive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
417,1159580,2,1,,268736006,444539,Active,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
418,1167300,1,2,,103198631,444539,Unspecified,,,1727620.0,IC50,Antioxidant activity assessed as DPPH radical scavenging activity incubated at room temperature for 20 mins by UV-visible spectrophotometry,Confirmatory,25278230.0,
419,1168255,1,1,,103198631,444539,Active,,,0.685,IC50,Inhibition of tankyrase in human DLD1 cells assessed as reduction in Wnt activity after 24 hrs by TCF-luciferase reporter gene assay,Confirmatory,25299683.0,
420,1191124,1,2,,103198631,444539,Unspecified,,,,,Inhibition of Pseudomonas aeruginosa recombinant PqsD expressed in Escherichia coli BL21 (lambdaDE3) using ACoA/beta-ketodecanoic acid as substrate at 50 uM after 10 mins,Other,25437621.0,
421,1191128,1,1,,103198631,444539,Unspecified,,,,,Inhibition of Pseudomonas aeruginosa PA14 PqsH transposon mutant assessed as extracellular level of HHQ at 250 uM after 16 hrs,Other,25437621.0,
422,1204254,1,1,,103198631,444539,Unspecified,,,,,Antibacterial activity against penicillin-susceptible Bacillus subtilis ATCC 9372 after 24 hrs by broth microdilution method,Other,25938986.0,
423,1204255,1,1,,103198631,444539,Unspecified,,,,,Antibacterial activity against penicillin-susceptible Escherichia coli ATCC 25922 after 24 hrs by broth microdilution method,Other,25938986.0,
424,1204256,1,1,,103198631,444539,Unspecified,,,,,Antibacterial activity against penicillin-susceptible Pseudomonas aeruginosa ATCC 27853 after 24 hrs by broth microdilution method,Other,25938986.0,
425,1204257,1,1,,103198631,444539,Unspecified,,,,,Antibacterial activity against penicillin-susceptible Staphylococcus aureus ATCC 25923 after 24 hrs by broth microdilution method,Other,25938986.0,
426,1204258,1,1,,103198631,444539,Unspecified,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 after 24 hrs by broth microdilution method,Other,25938986.0,
427,1204259,1,1,,103198631,444539,Unspecified,,,,,Antibacterial activity against penicillin-resistant Staphylococcus aureus clinical isolates after 24 hrs by broth microdilution method,Other,25938986.0,
428,1204260,1,1,,103198631,444539,Unspecified,,,,,Antibacterial activity against penicillin-resistant Staphylococcus epidermidis clinical isolates after 24 hrs by broth microdilution method,Other,25938986.0,
429,1204261,1,1,,103198631,444539,Unspecified,,,,,Antibacterial activity against penicillin-susceptible Streptococcus pyogenes clinical isolates after 24 hrs by broth microdilution method,Other,25938986.0,
430,1204262,1,1,,103198631,444539,Unspecified,,,,,Antibacterial activity against penicillin-resistant Streptococcus pyogenes clinical isolates after 24 hrs by broth microdilution method,Other,25938986.0,
431,1204263,1,1,,103198631,444539,Unspecified,,,,,Inhibition of cell division in penicillin-susceptible Bacillus subtilis ATCC 9372 assessed as filamentation after 5 hrs by phase contrast microscopy,Other,25938986.0,
432,1204264,1,1,,103198631,444539,Unspecified,,,,,Inhibition of cell division in penicillin-susceptible Escherichia coli ATCC 25922 assessed as filamentation after 5 hrs by phase contrast microscopy,Other,25938986.0,
433,1204265,1,1,,103198631,444539,Unspecified,,,,,Inhibition of cell division in penicillin-susceptible Pseudomonas aeruginosa ATCC 27853 assessed as filamentation after 5 hrs by phase contrast microscopy,Other,25938986.0,
434,1204266,1,1,,103198631,444539,Unspecified,,,,,Inhibition of cell division in penicillin-susceptible Staphylococcus aureus ATCC 25923 assessed as ballooning after 5 hrs by phase contrast microscopy,Other,25938986.0,
435,1224834,3,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
436,1224835,1,1,,144212454,444539,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
437,1224836,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
438,1224837,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
439,1224838,1,1,,144212454,444539,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
440,1224839,1,1,,144212454,444539,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
441,1224840,3,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
442,1224841,3,1,,144212454,444539,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
443,1224842,3,1,,144212454,444539,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
444,1224843,1,1,,144212454,444539,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
445,1224844,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
446,1224845,1,1,,144212454,444539,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
447,1224846,1,1,,144212454,444539,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
448,1224847,1,1,,144212454,444539,Inconclusive,,,1.791,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
449,1224848,3,1,,144212454,444539,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
450,1224849,3,1,,144212454,444539,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
451,1224867,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
452,1224868,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
453,1224869,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
454,1224870,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
455,1224871,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
456,1224872,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
457,1224873,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
458,1224874,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
459,1224875,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
460,1224876,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
461,1224877,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
462,1224878,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
463,1224879,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
464,1224880,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
465,1224881,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
466,1224882,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
467,1224883,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
468,1224884,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
469,1224885,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
470,1224886,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
471,1224887,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
472,1224888,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
473,1224889,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
474,1224890,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
475,1224892,1,1,,144212454,444539,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
476,1224893,1,1,,144212454,444539,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
477,1224894,1,1,,144212454,444539,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
478,1224895,1,1,,144212454,444539,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
479,1224896,1,1,,144212454,444539,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
480,1239713,1,1,,103198631,444539,Unspecified,,,,,Anti-platelet activity in rat platelet rich plasma assessed as inhibition of ADP and calcium-induced platelet aggregation at 100 uM pre-incubated at 37 degC for 10 mins and measured 30 mins after ADP and calcium addition,Other,26096681.0,
481,1259241,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
482,1259242,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
483,1259243,1,1,,144212454,444539,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
484,1259244,1,1,,144212454,444539,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
485,1259247,1,1,,144212454,444539,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
486,1259248,1,1,,144212454,444539,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
487,1259310,1,1,,321949507,444539,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
488,1259344,1,1,,144205832,444539,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
489,1259355,1,1,,144205832,444539,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-1,Confirmatory,,
490,1259356,1,1,,144205832,444539,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-2,Confirmatory,,
491,1259364,1,1,,144212454,444539,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
492,1259365,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
493,1259366,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
494,1259367,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
495,1259368,1,1,,144212454,444539,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
496,1259369,1,1,,144212454,444539,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
497,1259377,1,1,,144212454,444539,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
498,1259378,1,1,,144212454,444539,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
499,1259379,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
500,1259380,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
501,1259381,1,1,,144212454,444539,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
502,1259382,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
503,1259383,1,1,,144212454,444539,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
504,1259384,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
505,1259385,1,1,,144212454,444539,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
506,1259386,1,1,,144212454,444539,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
507,1259387,1,1,,144212454,444539,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
508,1259388,1,1,,144212454,444539,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
509,1259390,1,1,,144212454,444539,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
510,1259391,1,1,,144212454,444539,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
511,1259392,1,1,,144212454,444539,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
512,1259393,1,1,,144212454,444539,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
513,1259394,1,1,,144212454,444539,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
514,1259395,1,1,,144212454,444539,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
515,1259396,1,1,,144212454,444539,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
516,1259401,1,1,,144212454,444539,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
517,1259402,1,1,,144212454,444539,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
518,1259403,1,1,,144212454,444539,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
519,1259404,1,1,,144212454,444539,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
520,1259407,1,1,,363901140,444539,Inactive,,,,,CCRIS mutagenicity studies,Other,,
521,1259409,1,1,,363901140,444539,Unspecified,,,,,CCRIS tumor inhibitor studies,Other,,
